160 related articles for article (PubMed ID: 36056624)
21. RET(Men2B)-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfr alpha-1(-/-) mice.
Rajan I; Gestblom C; Kapur RP
Pediatr Dev Pathol; 2001; 4(5):446-53. PubMed ID: 11779046
[TBL] [Abstract][Full Text] [Related]
22. Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B.
Hidalgo A; Medrano ME; Rodrìguez S; Franco C; Martinez I; Benítez L; Salcedo M
J Exp Clin Cancer Res; 1998 Jun; 17(2):149-52. PubMed ID: 9700574
[TBL] [Abstract][Full Text] [Related]
23. Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series.
van den Broek MFM; Rijks EBG; Nikkels PGJ; Wolters VM; van Es RJJ; van Santen HM; van Nesselrooij BPM; Vriens MR; van Leeuwaarde RS; Valk GD; Verrijn Stuart AA
Endocrine; 2021 Jun; 72(3):905-914. PubMed ID: 33474713
[TBL] [Abstract][Full Text] [Related]
24. RET activation by germline MEN2A and MEN2B mutations.
Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
[TBL] [Abstract][Full Text] [Related]
25. Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation.
Bennaceur-Griscelli A; Hadoux J; Féraud O; Opolon P; Divers D; Gobbo E; Schlumberger M; Griscelli F; Turhan AG
Stem Cell Res; 2017 Aug; 23():154-157. PubMed ID: 28925363
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
Raue F; Dralle H; Machens A; Bruckner T; Frank-Raue K
J Clin Endocrinol Metab; 2018 Jan; 103(1):235-243. PubMed ID: 29077903
[TBL] [Abstract][Full Text] [Related]
27. Severe constipation as the first clinical manifestation in multiple endocrine neoplasia type 2B: a case report and literature review.
Zhang L; Guo Y; Ye L; Lu W; Dong Z; Wang W; Xiao Y
BMC Pediatr; 2020 Jun; 20(1):318. PubMed ID: 32600305
[TBL] [Abstract][Full Text] [Related]
28. Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice.
Gestblom C; Sweetser DA; Doggett B; Kapur RP
Am J Pathol; 1999 Dec; 155(6):2167-79. PubMed ID: 10595945
[TBL] [Abstract][Full Text] [Related]
29. Frequency and impact of musculoskeletal symptoms on quality of life in MEN2B.
Henderson JW; Montebello A; Grey J; Druce M
Clin Endocrinol (Oxf); 2023 Feb; 98(2):221-228. PubMed ID: 36161316
[TBL] [Abstract][Full Text] [Related]
30. Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase.
Marshall GM; Peaston AE; Hocker JE; Smith SA; Hansford LM; Tobias V; Norris MD; Haber M; Smith DP; Lorenzo MJ; Ponder BA; Hancock JF
Cancer Res; 1997 Dec; 57(23):5399-405. PubMed ID: 9393766
[TBL] [Abstract][Full Text] [Related]
31. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
[TBL] [Abstract][Full Text] [Related]
32. Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy.
Geiger JL; Chiosea SI; Challinor SM; Nikiforova MN; Bauman JE
Endocr Relat Cancer; 2015 Oct; 22(5):L19-22. PubMed ID: 26285607
[No Abstract] [Full Text] [Related]
33. [Genotype-phenotype correlations in multiple endocrine neoplasia type 2].
Zhang XW; Wang JY; Zhang YB; Wan HF; Zhang B; Yan DG; Liu WS; Xu ZG; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):538-41. PubMed ID: 27480304
[TBL] [Abstract][Full Text] [Related]
34. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.
Asai N; Murakami H; Iwashita T; Takahashi M
J Biol Chem; 1996 Jul; 271(30):17644-9. PubMed ID: 8663426
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary medullary thyroid cancer in a family with MEN2B: clinical analysis and mutation detection of RET proto-oncogene].
Zhang Y; Zhang B; Liu W; Yang L; Xu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 49(5):422-4. PubMed ID: 25017234
[No Abstract] [Full Text] [Related]
36. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
37. MEN2B syndrome - paediatric case report.
Zendran I; Szlasa W; Bis G; Sondaj K; Barg E
Pediatr Endocrinol Diabetes Metab; 2020; 26(4):211-215. PubMed ID: 33191720
[TBL] [Abstract][Full Text] [Related]
38. Single oligoarray-based detection of specific M918T mutation in RET oncogene in multiple endocrine neoplasia type 2B.
Pacheco-Rivera RA; Hernández-Zamora E; González-Yebra B; Beattie K; Maldonado-Rodríguez R; Santiago-Hernández JC; Medrano-Ortiz de Zárate ME; Salcedo M
Clin Exp Med; 2011 Dec; 11(4):227-34. PubMed ID: 21253810
[TBL] [Abstract][Full Text] [Related]
39. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
Lodish MB; Stratakis CA
Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
[TBL] [Abstract][Full Text] [Related]
40. Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes.
Xing S; Smanik PA; Oglesbee MJ; Trosko JE; Mazzaferri EL; Jhiang SM
Endocrinology; 1996 May; 137(5):1512-9. PubMed ID: 8612479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
